Advertisement

ASO Author Reflections: An Optimal Biological Model for Successful Drug Discovery

  • V. Craig JordanEmail author
ASO Author Reflections
  • 15 Downloads

Notes

Disclosure

V. Craig Jordan has no conflicts of interest to disclose.

References

  1. 1.
    Baumler E, Ehrlich P. Scientist for life. New York: Holmes B. Meyer; 1984.Google Scholar
  2. 2.
    Jordan VC. Scientific Survival Suggestions (Appendix 1). In: Jordan VC, editor. Estrogen action, selective estrogen receptor modulators and women’s health: progress and promise. London: Imperial College Press; 2013. p. 459–64.CrossRefGoogle Scholar
  3. 3.
    Jordan VC. Selective estrogen receptor modulation: a personal perspective. Cancer Res. 2003;61:5683–7.Google Scholar
  4. 4.
    Maximov PY, McDaniel RE, Jordan VC. Tamoxifen: milestones in drug therapy. Basel: Springer; 2013.Google Scholar
  5. 5.
    Jordan VC. The SERM saga, something from nothing: American Cancer Society/SSO basic science lecture. Ann Surg Oncol. Epub 25 Mar 2019.  https://doi.org/10.1245/s10434-019-07291-1.
  6. 6.
    Maximov PY, Lee TM, Jordan VC. The discovery and development of selective estrogen receptor modulators (SERMs) for clinical practice. Curr Clin Pharmacol. 2013;8:135–55.CrossRefPubMedGoogle Scholar

Copyright information

© Society of Surgical Oncology 2019

Authors and Affiliations

  1. 1.University of Texas MD Anderson Cancer CenterHoustonUSA

Personalised recommendations